Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BDH IndustriesBOM:524828 +0.46%78 Pretax Margin % is 15.81% as of Mar. 2026, which is 9% above its 10-year median of 14.47. GuruFocus rates BOM:524828 with a GF Score™ of 78/100 and a GF Value™ of ₹391.10 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 960 Drug Manufacturers companies, BDH Industries ranks better than 72.4% on this metric.
The historical rank and industry rank for BDH Industries's Pretax Margin % or its related term are showing as below:
BOM:524828'
s Pretax Margin % Range Over the Past 10 Years
Min: 11.65 Med: 14.47 Max: 19.21
Current: 15.83
BOM:524828's Pretax Margin % is ranked better than 72.4% of 960
companies
in the Drug Manufacturers industry
Industry Median: 7.28
vs BOM:524828: 15.83
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
BDH Industries Pretax Margin % Related Terms
BDH Industries Pretax Margin % Historical Data
* Premium members only.
The historical data trend for BDH Industries's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BDH Industries's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BDH Industries Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BDH Industries's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where BDH Industries's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BDH Industries (BOM:524828) has a Pretax Margin % of 15.81% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on BDH Industries and its competitors. This is near median its historical median of 14.47. Over the past decade, BDH Industries' Pretax Margin % has ranged from 11.65 to 19.21. According to the industry distribution chart, BDH Industries ranks #265 out of 960 companies in the Drug Manufacturers industry, placing it in the top 27.6%.
Is BDH Industries' Pretax Margin % too high?
BDH Industries' current Pretax Margin % of 15.81% is near median its 10-year median of 14.47. Over the past 10 years, this metric has ranged from a low of 11.65 to a high of 19.21. The Drug Manufacturers industry median Pretax Margin % is 7.28. BDH Industries' value of 15.81% is 117.2% above this industry median. Based on the distribution chart, BDH Industries ranks #265 out of 960 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, BDH Industries has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BDH Industries' Pretax Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, BDH Industries ranks #265 out of 960 companies for Pretax Margin %. This puts BDH Industries in the upper half of its industry. The industry median Pretax Margin % is 7.28. BDH Industries' value of 15.81% is 117.2% above this benchmark. Historically, BDH Industries' own Pretax Margin % has ranged from 11.65 to 19.21 over the past decade. While the company's 10-year median is 14.47 vs. the industry median of 7.28, BDH Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BDH Industries's current Pretax Margin % of 15.81% is 117.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on BDH Industries and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BDH Industries's current Pretax Margin % is 15.81%, which is near median its own 10-year median of 14.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BDH Industries stock overvalued right now?
Based on GuruFocus' analysis, BDH Industries (BOM:524828) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹391.10, compared to a current price of ₹581.35 — trading 48.6% above its estimated fair value. The current Pretax Margin % is 15.81%, which is near median its 10-year median of 14.47 and 117.2% above the Drug Manufacturers industry median of 7.28. BDH Industries' overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For BDH Industries (BOM:524828), the current Pretax Margin % is 15.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BDH Industries (BOM:524828) Overvalued in 2026?
Based on GuruFocus' analysis, BDH Industries stock appears to be overvalued.
The current stock price of ₹581.35 is trading 48.6% above its estimated GF Value™ of ₹391.10.
GuruFocus considers BDH Industries to be Significantly Overvalued.
Key valuation signals for BOM:524828:
Pretax Margin %: 15.81% (near median its 10-year median of 14.47)
GF Value™: ₹391.10 vs. price of ₹581.35 (48.6% above fair value)
Industry Position: 117.2% above the Drug Manufacturers median (#265 of 960)
No single metric tells the full story. See the BOM:524828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BDH Industries Ltd is an India based pharmaceutical company. It is engaged in the manufacturing of therapeutic formulations including various pharmaceuticals. The company has the following reportable segments; Pharmaceuticals and Renewable Energy. The majority of its revenue is generated from the Pharmaceuticals segment. The company's product portfolio encompasses therapeutic categories including antifungal, antibiotics, anticancer, antidiabetic, antidepressant, antiulcerant, antimalarials, anti-inflammatory, analgesic, antispasmodic, anti-tuberculosis, cardiovascular, dermatological, psychotropic, and others.
78GF Score
Get the complete analysis for BOM:524828
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524828 has been successfully added to your 
